MENU
+Compare
UNCY
Stock ticker: NASDAQ
AS OF
Dec 18, 04:59 PM (EDT)
Price
$0.66
Change
-$0.04 (-5.71%)
Capitalization
72.61M

UNCY Unicycive Therapeutics Forecast, Technical & Fundamental Analysis

Industry Biotechnology
UNCY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
a Summary for UNCY with price predictions
Dec 17, 2024

UNCY saw its Stochastic Oscillator leaves the overbought zone

The Stochastic Oscillator for UNCY moved out of overbought territory on December 12, 2024. This could be a bearish sign for the stock and investors may want to consider selling or taking a defensive position. A.I.dvisor looked at 32 similar instances where the indicator exited the overbought zone. In of the 32 cases the stock moved lower. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for UNCY moved out of overbought territory on December 12, 2024. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 14 similar instances where the indicator moved out of overbought territory. In of the 14 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Momentum Indicator moved below the 0 level on December 16, 2024. You may want to consider selling the stock, shorting the stock, or exploring put options on UNCY as a result. In of 63 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for UNCY turned negative on December 16, 2024. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 32 similar instances when the indicator turned negative. In of the 32 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where UNCY declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

UNCY broke above its upper Bollinger Band on November 27, 2024. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where UNCY advanced for three days, in of 140 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 78 cases where UNCY Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. UNCY’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.607) is normal, around the industry mean (14.664). P/E Ratio (0.000) is within average values for comparable stocks, (87.689). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.783). UNCY has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.012). P/S Ratio (39.216) is also within normal values, averaging (260.687).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. UNCY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
UNCY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

UNCY is expected to report earnings to rise 82.80% to -9 cents per share on March 27

Unicycive Therapeutics UNCY Stock Earnings Reports
Q4'24
Est.
$-0.09
Q3'24
Beat
by $0.10
Q2'24
Missed
by $0.09
Q1'24
Missed
by $0.82
Q4'23
Missed
by $0.04
The last earnings report on November 13 showed earnings per share of -5 cents, beating the estimate of -15 cents. With 625.60K shares outstanding, the current market capitalization sits at 72.61M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
4300 El Camino Real
Phone
+1 650 351-4495
Employees
14
Web
https://www.unicycive.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GNL7.290.16
+2.24%
Global Net Lease
MLP22.170.03
+0.14%
Maui Land & Pineapple Co
BHP51.00-0.11
-0.22%
BHP Group Limited
ACHC39.64-0.84
-2.08%
Acadia Healthcare Company
VIGL1.73-0.14
-7.49%
Vigil Neuroscience

UNCY and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, UNCY has been loosely correlated with BLPH. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if UNCY jumps, then BLPH could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To UNCY
1D Price
Change %
UNCY100%
-0.07%
BLPH - UNCY
35%
Loosely correlated
N/A
BBIO - UNCY
32%
Poorly correlated
+0.40%
SLDB - UNCY
29%
Poorly correlated
-3.04%
SCPX - UNCY
28%
Poorly correlated
-1.82%
MRKR - UNCY
26%
Poorly correlated
+17.68%
More